EZR and colorectal carcinoma: Another study by Mori et al. demonstrated the higher expression levels of ezrin in LN-positive CRC using iTRAQ-based proteomic approaches and subsequently validated its expression at protein as well as mRNA levels in an independent cohort of samples using IHCs and RT-PCR, respectively.